Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02428244 · ClinicalTrials.gov registry record · NA

Let's STOP Now Trial: Smoking in Trauma Orthopaedic Patients

A NA study, sponsored by University of Maryland, Baltimore.

Completed
Registry status
NA
Development phase
269
Enrollment target

NCT02428244: Completed NA study, sponsored by University of Maryland, Baltimore.

NCT02428244 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 269 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02428244, a NA study, has completed, sponsored by University of Maryland, Baltimore.

COMPLETED
Registry status
NA
Development phase
269 participants
Enrollment target

Study Summary

It is well known that smoking has deleterious effects to fracture/broken bone outcomes. Complications associated with smoking can be mitigated by smoking cessation. Initiating smoking cessation programs while patients are in the inpatient hospital setting has shown to be an opportune time to enroll patients in a smoking cessation program. The goal of this study is to determine if inpatient smoking counseling with/without follow-up is superior to the standard smoking cessation information associated with admission to a hospital facility.

Primary Outcome

Self-reported 7-day abstinence from smoking at 2 weeks

Interventions

  • BEHAVIORAL Motivational Interviewing
  • BEHAVIORAL Motivational Interviewing + Follow-up

Trial Details

FieldValue
Enrollment Target 269 participants
Start Date 2014-11
Est. Completion 2019-04-01
Phase NA
University of Maryland, Baltimore

560 total trials

What the finished NCT02428244 record still lists

NCT02428244 is an interventional study that assigns participants to a tested intervention. The registered 269 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).

The record links to 0 conditions, and to 2 interventions - of which Motivational Interviewing is the first listed.

NCT02428244 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02428244 about?

NCT02428244 is a clinical study titled "Let's STOP Now Trial: Smoking in Trauma Orthopaedic Patients". It is well known that smoking has deleterious effects to fracture/broken bone outcomes. Complications associated with smoking can be mitigated by smoking cessation. Initiating smoking cessation programs while patients are in the inpatient hospital setting has shown to be an opportune time to enroll ...

What is the current status of trial NCT02428244?

This trial is currently completed. It is a NA study. The enrollment target is 269 participants. The study started on 2014-11. Estimated completion is 2019-04-01.

What interventions are being tested in trial NCT02428244?

The interventions under investigation include: Motivational Interviewing (BEHAVIORAL), Motivational Interviewing + Follow-up (BEHAVIORAL).

Who is sponsoring clinical trial NCT02428244?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02428244's enrollment target sits among peer trials

269 392nd of 2000 higher than 1,609 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04802291 · 269 participants · NA

    HomeStyles-2: Shaping HOME Environments and LifeSTYLES to Prevent Childhood Obesity

  • NCT06500455 · 269 participants · Phase 3

    Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

  • NCT06630676 · 269 participants · NA

    The Ability of Chronic Pain Patients to Self-diagnose Their Chief Source of Low Back Pain

  • NCT00801489 · 270 participants · Phase 2

    Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02428244, the US trial registry maintained by the National Library of Medicine. NCT02428244 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.